32 assets in Ovarian Clear Cell Adenocarcinoma

Therapeutic assets addressing Ovarian Clear Cell Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Ovarian Clear Cell Adenocarcinoma	NRG Oncology	P3	BBB (72)
Olaparib Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P3	BB (70)
Adriamycin Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P3	BB (69)
Cediranib Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P3	BB (67)
Cyclophosphamide Ovarian Clear Cell Adenocarcinoma	Roswell Park Cancer Institute	P2	BB (66)
Pembrolizumab Ovarian Clear Cell Adenocarcinoma	Roswell Park Cancer Institute	P2	B (63)
Nogitecan Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P2/3	B (62)
Docetaxel Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P3	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (60)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (59)
Atezolizumab Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P2/3	B (57)
Catequentinib Ovarian Clear Cell Adenocarcinoma	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2	B (57)
Niraparib Ovarian Clear Cell Adenocarcinoma	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2	B (57)
Adsorbed Purified Pertussis Vaccine Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	CCC (53)
Diphtheria Toxoid Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	CCC (53)
Diphtheria Toxoid Adsorbed Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	CCC (53)
Durvalumab Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Ipilimumab Ovarian Clear Cell Adenocarcinoma	Brown University	P2	CCC (53)
Lorigerlimab Ovarian Clear Cell Adenocarcinoma	MacroGenics	P2	CCC (53)
Nivolumab Ovarian Clear Cell Adenocarcinoma	Brown University	P2	CCC (53)
Pegcetacoplan Ovarian Clear Cell Adenocarcinoma	Roswell Park Cancer Institute	P2	CCC (53)
Tazemetostat Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Tetanus Toxoid Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	CCC (53)
Cdx 1140 Ovarian Clear Cell Adenocarcinoma	Roswell Park Cancer Institute	P2	CCC (51)
Tolinapant Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P1/2	CC (47)
Amt-151 Ovarian Clear Cell Adenocarcinoma	Multitude Therapeutics Inc.	P1	CC (43)
Bet Bromodomain Inhibitor Zen-3694 Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (43)
Capivasertib Ovarian Clear Cell Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Cytokine-Induced Memory-Like Natural Killer Cells Ovarian Clear Cell Adenocarcinoma	Dana-Farber Cancer Institute	P1	CC (43)
Ipn 60090 Ovarian Clear Cell Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
nxp800 Ovarian Clear Cell Adenocarcinoma	Nuvectis Pharma, Inc.	P1	CC (43)
Tuvusertib Ovarian Clear Cell Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (43)